Phase III ALTU-135 CP Safety Trial

NCT00500084 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

39

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision.

Conditions

Exocrine Pancreatic Insufficiency

Interventions

DRUG: Liprotamase

Sponsor

Anthera Pharmaceuticals